This Week in Cancer Discovery | GenomeWeb

This Week in Cancer Discovery

Premium

In Cancer Discovery this week, researchers in the UK and Switzerland report they performed a functional metabolic screen to identify the gene PFKFB4 as an important regulator of prostate cancer cell survival. The team analyzed the effect of silencing 222 different enzymes, transporters, and regulators on the survival of three metastatic prostate cancer cell lines and one non-malignant prostate cancer cell line and found that there are several genes required for the cells' survival.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.